BACKGROUND: The best treatment method for large tibial bone defects during revision knee replacement has not been established. The purpose of this study was to determine the initial results obtained with a unique reconstructive implant, the porous tantalum metaphyseal cone, designed as an alternative treatment for severe tibial bone loss following total knee arthroplasty.
METHODS: Porous tantalum metaphyseal cones were implanted during fifteen revision total knee replacements in eight women and seven men who had an average age of 68.1 years at the time of the procedure. The patients had had an average of 3.5 prior total knee replacements. According to the Anderson Orthopaedic Research Institute bone defect classification, eight knees had a Type-3 defect and seven knees had a Type-2B bone defect. All patients were followed clinically and radiographically.
RESULTS: The patients were followed for an average of thirty-four months (range, twenty-four to forty-seven months). Overall, the average Knee Society clinical scores improved from 52 points preoperatively to 85 points at the time of the final follow-up. At the final follow-up evaluation, all fifteen porous metaphyseal cones showed evidence of osseointegration with reactive osseous trabeculation at points of contact with the tibia. There was no evidence of loosening or migration of any of these tibial reconstructions at the time of final follow-up.
CONCLUSIONS: At the time of short-term follow-up, the porous tantalum metaphyseal tibial cones effectively provided structural support for the tibial implants in this series. The potential for long-term biologic fixation may provide durability for these tibial reconstructions. Long-term follow-up and comparison with alternative reconstructive techniques will be required to evaluate the true effectiveness of this treatment approach.
LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.
The original scientific article in which the surgical technique was presented was published in JBJS Vol. 90-A, pp. 78-84, January 2008
DISCLOSURE: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. One or more of the authors or a member of his or her immediate family received, in any one year, payments or other benefits in excess of $10,000 or a commitment or agreement to provide such benefits from a commercial entity (Zimmer). Also, commercial entities (Zimmer and Stryker) paid or directed in any one year, or agreed to pay or direct, benefits in excess of $10,000 to a research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which one or more of the authors, or a member of his or her immediate family, is affiliated or associated.
Investigation performed at the Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota
- Copyright © 2009 by The Journal of Bone and Joint Surgery, Incorporated
Enter your JBJS login information below.